Reviewed,
UniProtKB/Swiss-Prot Q14155 (ARHG7_HUMAN)
Last modified
November 25, 2008.
Version 94.
History...
Clusters with 100%,
90%,
50% identity |
Documents (5) |
Third-party data |
Customize display | text xml rdf/xml gff fasta |
Names and origin
| Protein names | Recommended name: Rho guanine nucleotide exchange factor 7 Alternative name(s): PAK-interacting exchange factor beta Beta-Pix COOL-1 p85 | ||||||
| Gene names |
| ||||||
| Organism | Homo sapiens (Human) | ||||||
| Taxonomic identifier | 9606 [NCBI] | ||||||
| Taxonomic lineage | Eukaryota › Metazoa › Chordata › Craniata › Vertebrata › Euteleostomi › Mammalia › Eutheria › Euarchontoglires › Primates › Haplorrhini › Catarrhini › Hominidae › Homo |
Protein attributes
| Sequence length | 803 AA. |
| Sequence status | Complete. |
| Sequence processing | The displayed sequence is not processed. |
| Protein existence | Evidence at protein level. |
General annotation (Comments)
| Function | Acts as a RAC1 guanine nucleotide exchange factor (GEF) and can induce membrane ruffling By similarity. |
| Subunit structure | Interacts with PAK kinases through the SH3 domain. Interacts with GIT1 and TGFB1I1. Interacts with ITCH By similarity. Interacts with unphosphorylated PAK1. |
| Sequence similarities | Contains 1 CH (calponin-homology) domain. Contains 1 DH (DBL-homology) domain. Contains 1 PH domain. Contains 1 SH3 domain. |
Ontologies
Keywords | |
|---|---|
| Coding sequence diversity | Alternative splicing |
| Domain | SH3 domain |
| Molecular function | Guanine-nucleotide releasing factor |
| PTM | Phosphoprotein |
| Technical term | 3D-structure |
Gene Ontology (GO) | |
| Biological process | regulation of Rho protein signal transduction Inferred from electronic annotation. Source: InterPro |
| Cellular component | cytosol Inferred from Experiment. Source: Reactome nucleolusInferred from direct assay. Source: HPA |
| Molecular function | Rho guanyl-nucleotide exchange factor activity Inferred from electronic annotation. Source: InterPro |
| Complete GO annotation... | |
Alternative products
| This entry describes 6 isoforms produced by alternative splicing. [Align] [Select] | ||||||
| Isoform 4 (identifier: Q14155-4) This isoform has been chosen as the 'canonical' sequence. All positional information in this entry refers to it. This is also the sequence that appears in the downloadable versions of the entry. | ||||||
| Isoform 1 (identifier: Q14155-1) The sequence of this isoform differs from the canonical sequence as follows: 1-178: Missing. 733-803: TWQGTDLMHN...SCCSYISHQN → SSRKESAPQV...NDPAWDETNL | ||||||
| Isoform 2 (identifier: Q14155-2) The sequence of this isoform differs from the canonical sequence as follows: 56-105: Missing. | ||||||
| Isoform 3 (identifier: Q14155-3) The sequence of this isoform differs from the canonical sequence as follows: 85-105: Missing. | ||||||
| Isoform 5 (identifier: Q14155-5) The sequence of this isoform differs from the canonical sequence as follows: 85-177: Missing. 733-803: TWQGTDLMHN...SCCSYISHQN → SSRKESAPQV...NDPAWDETNL | ||||||
| Isoform 6 (identifier: Q14155-6) The sequence of this isoform differs from the canonical sequence as follows: 1-178: Missing. |
Sequence annotation (Features)
| Feature key | Position(s) | Length | Description | Graphical view | Feature identifier | |||||||||||||||||||||||||||||||||||||
Molecule processing | ||||||||||||||||||||||||||||||||||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Chain | 1 – 803 | 803 | Rho guanine nucleotide exchange factor 7 | PRO_0000080921 | ||||||||||||||||||||||||||||||||||||||
Regions | ||||||||||||||||||||||||||||||||||||||||||
| Domain | 1 – 132 | 132 | CH | |||||||||||||||||||||||||||||||||||||||
| Domain | 184 – 243 | 60 | SH3 | |||||||||||||||||||||||||||||||||||||||
| Domain | 271 – 451 | 181 | DH | |||||||||||||||||||||||||||||||||||||||
| Domain | 473 – 578 | 106 | PH | |||||||||||||||||||||||||||||||||||||||
Amino acid modifications | ||||||||||||||||||||||||||||||||||||||||||
| Modified residue | 176 | 1 | Phosphoserine By similarity | |||||||||||||||||||||||||||||||||||||||
| Modified residue | 249 | 1 | Phosphoserine | |||||||||||||||||||||||||||||||||||||||
| Modified residue | 518 | 1 | Phosphoserine | |||||||||||||||||||||||||||||||||||||||
| Modified residue | 694 | 1 | Phosphoserine | |||||||||||||||||||||||||||||||||||||||
Natural variations | ||||||||||||||||||||||||||||||||||||||||||
| Alternative sequence | 1 – 178 | 178 | Missing in isoform 1 and isoform 6. | VSP_011032 | ||||||||||||||||||||||||||||||||||||||
| Alternative sequence | 56 – 105 | 50 | Missing in isoform 2. | VSP_011033 | ||||||||||||||||||||||||||||||||||||||
| Alternative sequence | 85 – 177 | 93 | Missing in isoform 5. | VSP_034639 | ||||||||||||||||||||||||||||||||||||||
| Alternative sequence | 85 – 105 | 21 | Missing in isoform 3. | VSP_011034 | ||||||||||||||||||||||||||||||||||||||
| Alternative sequence | 733 – 803 | 71 | TWQGT…ISHQN → SSRKESAPQVLLPEEEKIIV EETKSNGQTVIEEKSLVDTV YALKDEVQELRQDNKKMKKS LEEEQRARKDLEKLVRKVLK NMNDPAWDETNL in isoform 1 and isoform 5. | VSP_011035 | ||||||||||||||||||||||||||||||||||||||
Experimental info | ||||||||||||||||||||||||||||||||||||||||||
| Sequence conflict | 52 – 55 | 4 | TIEK → EEKR in BAD66827. Ref.7 | |||||||||||||||||||||||||||||||||||||||
| Sequence conflict | 343 | 1 | Q → K in AAH33905. Ref.6 | |||||||||||||||||||||||||||||||||||||||
| Sequence conflict | 552 | 1 | M → V in AAH33905. Ref.6 | |||||||||||||||||||||||||||||||||||||||
| Sequence conflict | 595 | 1 | H → D in BAD66827. Ref.7 | |||||||||||||||||||||||||||||||||||||||
| Sequence conflict | 636 | 1 | I → T in AAH50521. Ref.6 | |||||||||||||||||||||||||||||||||||||||
| Sequence conflict | 740 | 1 | M → L in AAH33905. Ref.6 | |||||||||||||||||||||||||||||||||||||||
Secondary structure | ||||||||||||||||||||||||||||||||||||||||||
Helix Strand Turn | ||||||||||||||||||||||||||||||||||||||||||
| Beta strand | 188 – 191 | 4 | ||||||||||||||||||||||||||||||||||||||||
| Beta strand | 210 – 215 | 6 | ||||||||||||||||||||||||||||||||||||||||
| Beta strand | 218 – 226 | 9 | ||||||||||||||||||||||||||||||||||||||||
| Beta strand | 229 – 240 | 12 | ||||||||||||||||||||||||||||||||||||||||
| Helix | 271 – 301 | 31 | ||||||||||||||||||||||||||||||||||||||||
| Turn | 302 – 304 | 3 | ||||||||||||||||||||||||||||||||||||||||
| Beta strand | 305 – 310 | 6 | ||||||||||||||||||||||||||||||||||||||||
| Helix | 311 – 313 | 3 | ||||||||||||||||||||||||||||||||||||||||
| Helix | 316 – 338 | 23 | ||||||||||||||||||||||||||||||||||||||||
| Helix | 346 – 378 | 33 | ||||||||||||||||||||||||||||||||||||||||
| Turn | 379 – 381 | 3 | ||||||||||||||||||||||||||||||||||||||||
| Helix | 382 – 385 | 4 | ||||||||||||||||||||||||||||||||||||||||
| Turn | 386 – 389 | 4 | ||||||||||||||||||||||||||||||||||||||||
| Turn | 395 – 397 | 3 | ||||||||||||||||||||||||||||||||||||||||
| Helix | 398 – 402 | 5 | ||||||||||||||||||||||||||||||||||||||||
| Turn | 406 – 408 | 3 | ||||||||||||||||||||||||||||||||||||||||
| Helix | 409 – 411 | 3 | ||||||||||||||||||||||||||||||||||||||||
| Helix | 413 – 422 | 10 | ||||||||||||||||||||||||||||||||||||||||
| Beta strand | 428 – 430 | 3 | ||||||||||||||||||||||||||||||||||||||||
| Helix | 432 – 453 | 22 | ||||||||||||||||||||||||||||||||||||||||
| Turn | 454 – 456 | 3 | ||||||||||||||||||||||||||||||||||||||||
Sequences
| ||||||||||||||||||||||||||||||||||||||||||||||||
References
| « Hide 'large scale' references | |
| [1] | "Prediction of the coding sequences of unidentified human genes. IV. The coding sequences of 40 new genes (KIAA0121-KIAA0160) deduced by analysis of cDNA clones from human cell line KG-1." Nagase T., Seki N., Tanaka A., Ishikawa K., Nomura N. DNA Res. 2:167-174(1995) [PubMed: 8590280] [Abstract] Cited for: NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA] (ISOFORM 1). Tissue: Bone marrow. |
| [2] | "A novel regulator of p21-activated kinases." Bagrodia S., Taylor S.J., Jordon K.A., Van Aelst L., Cerione R.A. J. Biol. Chem. 273:23633-23636(1998) [PubMed: 9726964] [Abstract] Cited for: NUCLEOTIDE SEQUENCE [MRNA] (ISOFORM 1). |
| [3] | The German cDNA consortium Submitted (JUL-2002) to the EMBL/GenBank/DDBJ databases Cited for: NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA] (ISOFORM 3). Tissue: Amygdala. |
| [4] | "The DNA sequence and analysis of human chromosome 13." Dunham A., Matthews L.H., Burton J., Ashurst J.L., Howe K.L., Ashcroft K.J., Beare D.M., Burford D.C., Hunt S.E., Griffiths-Jones S., Jones M.C., Keenan S.J., Oliver K., Scott C.E., Ainscough R., Almeida J.P., Ambrose K.D., Andrews D.T. Ross M.T.Nature 428:522-528(2004) [PubMed: 15057823] [Abstract] Cited for: NUCLEOTIDE SEQUENCE [LARGE SCALE GENOMIC DNA]. |
| [5] | Mural R.J., Istrail S., Sutton G.G., Florea L., Halpern A.L., Mobarry C.M., Lippert R., Walenz B., Shatkay H., Dew I., Miller J.R., Flanigan M.J., Edwards N.J., Bolanos R., Fasulo D., Halldorsson B.V., Hannenhalli S., Turner R. Venter J.C.Submitted (JUL-2005) to the EMBL/GenBank/DDBJ databases Cited for: NUCLEOTIDE SEQUENCE [LARGE SCALE GENOMIC DNA]. |
| [6] | "The status, quality, and expansion of the NIH full-length cDNA project: the Mammalian Gene Collection (MGC)." The MGC Project Team Genome Res. 14:2121-2127(2004) [PubMed: 15489334] [Abstract] Cited for: NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA] (ISOFORMS 1; 2 AND 4). Tissue: Brain and Testis. |
| [7] | "Alternative splice variants encoding unstable protein domains exist in the human brain." Homma K., Kikuno R.F., Nagase T., Ohara O., Nishikawa K. J. Mol. Biol. 343:1207-1220(2004) [PubMed: 15491607] [Abstract] Cited for: NUCLEOTIDE SEQUENCE [MRNA] OF 52-803 (ISOFORM 5). |
| [8] | "Neuroblastoma oligo-capping cDNA project: toward the understanding of the genesis and biology of neuroblastoma." Ohira M., Morohashi A., Nakamura Y., Isogai E., Furuya K., |

Clusters with